Share

The Estee Lauder Companies Inc. (EL.NYSE) AI OPINIONS & ADVISOR ANALYSIS

Read and compare the 14 individual AI Advisor deep-dive reports, including their forecast paths, ratings, price targets, and reasoning.

Updated on 20 September 2026Deep analysis 20 September 2026

Publisher

Russlan Ramdowar

25 min readAudit All Past Forecasts

14 AI Advisor Reports

Select an advisor report.

SynthesizerCombines all advisor views

Synthesis of 14 independent opinions

Diversity of ModelsSame approach, varied models

Diversity of FrameworksDifferent investing styles

AI Researcher

Opus 5

Universal Investor AI

The Polymath Framework

Model rating

Neutral

5-Year Return Est.

+54.4%

Includes 1.04% annual net dividend contribution

1. Investment Thesis — Base Case

The central tension is that Estee Lauder has fixed its cost base but not yet proved its demand engine. The $1.2bn PRGP benefit is banked and largely lands in FY2027, taking adjusted margin to roughly 13% and adjusted EPS to about $3.23 at the midpoint [10]. From there, progress requires volume: fragrance mix and Asian travel retail push forward, while a flat Chinese category and a stagnant Americas hold organic growth near 4%. Earnings compound respectably, but the starting multiple of roughly 29x forward against a 5% ten-year means the multiple gives back part of what earnings deliver.

Revenue compounding near 4% to roughly $18bn by FY2031, with operating margin grinding toward 15.5%.
That implies about $5.20 of on a roughly 360m share count, capitalised near 25x.
Cross-check: approximately $47bn equity value, versus $34.1bn today, before dividends of roughly 1.5%.

Historical prices and published forecast

Observed price
Published advisor forecast

Observed prices and the selected advisor's published projection share a split-adjusted price basis. Prices after the forecast start are later observations, not information known at publication. Forecasts are uncertain. Values in USD.

View chart values

Historical prices and published forecast — published chart values
Series	Date	Value (USD)
Observed price	2021-09-16	323
Observed price	2021-10-02	303
Observed price	2021-10-10	310
Observed price	2021-10-26	331
Observed price	2021-11-03	340
Observed price	2021-11-19	353
Observed price	2021-12-01	333
Observed price	2021-12-09	359
Observed price	2022-01-02	371
Observed price	2022-01-10	336
Observed price	2022-01-14	322
Observed price	2022-01-26	296
Observed price	2022-02-07	315
Observed price	2022-02-23	291
Observed price	2022-03-03	292
Observed price	2022-03-15	259
Observed price	2022-03-27	280
Observed price	2022-04-12	263
Observed price	2022-04-20	273
Observed price	2022-05-10	232
Observed price	2022-05-22	236
Observed price	2022-06-03	264
Observed price	2022-06-07	271
Observed price	2022-06-19	242
Observed price	2022-07-13	245
Observed price	2022-07-21	263
Observed price	2022-07-25	259
Observed price	2022-08-14	276
Observed price	2022-08-18	282
Observed price	2022-09-07	247
Observed price	2022-09-11	254
Observed price	2022-10-01	219
Observed price	2022-10-05	228
Observed price	2022-10-21	200
Observed price	2022-11-02	200
Observed price	2022-11-14	227
Observed price	2022-11-26	219
Observed price	2022-12-12	244
Observed price	2022-12-20	238
Observed price	2023-01-05	261
Observed price	2023-01-09	262
Observed price	2023-01-25	275
Observed price	2023-02-02	275
Observed price	2023-02-22	249
Observed price	2023-03-06	252
Observed price	2023-03-10	236
Observed price	2023-03-22	237
Observed price	2023-04-03	247
Observed price	2023-04-19	258
Observed price	2023-05-05	202
Observed price	2023-05-09	204
Observed price	2023-05-29	188
Observed price	2023-06-10	180
Observed price	2023-06-18	200
Observed price	2023-07-04	197
Observed price	2023-07-16	191
Observed price	2023-07-20	182
Observed price	2023-08-09	166
Observed price	2023-08-13	166
Observed price	2023-08-21	151
Observed price	2023-09-06	158
Observed price	2023-09-26	143
Observed price	2023-09-30	144
Observed price	2023-10-20	138
Observed price	2023-10-24	136
Observed price	2023-11-05	113
Observed price	2023-11-21	123
Observed price	2023-12-07	136
Observed price	2023-12-11	135
Observed price	2023-12-19	149
Observed price	2024-01-08	139
Observed price	2024-01-20	126
Observed price	2024-02-01	133
Observed price	2024-02-17	147
Observed price	2024-02-21	147
Observed price	2024-03-12	152
Observed price	2024-03-24	141
Observed price	2024-03-28	154
Observed price	2024-04-13	138
Observed price	2024-04-25	147
Observed price	2024-05-15	136
Observed price	2024-05-23	128
Observed price	2024-06-04	124
Observed price	2024-06-16	112
Observed price	2024-06-24	114
Observed price	2024-07-10	102
Observed price	2024-07-14	102
Observed price	2024-08-03	94.7
Observed price	2024-08-11	90.5
Observed price	2024-08-15	95.1
Observed price	2024-08-31	91.9
Observed price	2024-09-12	84.5
Observed price	2024-09-24	89.2
Observed price	2024-09-28	99.2
Observed price	2024-10-18	90.5
Observed price	2024-11-07	63.6
Observed price	2024-11-11	63.0
Observed price	2024-12-01	74.8
Observed price	2024-12-09	81.7
Observed price	2024-12-21	74.7
Observed price	2025-01-06	73.6
Observed price	2025-01-18	78.2
Observed price	2025-01-30	85.5
Observed price	2025-02-07	65.0
Observed price	2025-02-23	74.2
Observed price	2025-03-03	69.0
Observed price	2025-03-11	69.2
Observed price	2025-03-27	65.7
Observed price	2025-04-16	54.4
Observed price	2025-04-24	58.6
Observed price	2025-05-06	58.5
Observed price	2025-05-18	65.6
Observed price	2025-05-22	64.4
Observed price	2025-06-11	70.2
Observed price	2025-06-15	73.4
Observed price	2025-07-05	87.5
Observed price	2025-07-17	86.8
Observed price	2025-07-29	93.1
Observed price	2025-08-14	93.1
Observed price	2025-08-22	88.0
Observed price	2025-09-03	91.9
Observed price	2025-09-11	86.8
Observed price	2025-10-01	86.2
Observed price	2025-10-09	94.0
Observed price	2025-10-13	92.7
Observed price	2025-10-17	101
Observed price	2025-11-06	87.8
Observed price	2025-11-26	93.7
Observed price	2025-11-30	94.5
Observed price	2025-12-20	108
Observed price	2026-01-01	106
Observed price	2026-01-13	115
Observed price	2026-02-02	119
Observed price	2026-02-06	99.5
Observed price	2026-02-10	101
Observed price	2026-02-22	113
Observed price	2026-03-06	95.1
Observed price	2026-03-26	70.2
Observed price	2026-04-03	69.1
Observed price	2026-04-15	76.6
Observed price	2026-04-23	76.4
Observed price	2026-05-09	84.0
Observed price	2026-05-17	78.2
Observed price	2026-05-29	89.0
Observed price	2026-06-14	89.5
Observed price	2026-06-30	79.0
Observed price	2026-07-04	84.3
Observed price	2026-07-24	80.3
Observed price	2026-08-01	84.2
Observed price	2026-08-09	87.6
Observed price	2026-08-25	105
Observed price	2026-09-10	96.5
Observed price	2026-09-18	93.4
Observed price	2026-09-22	100
Observed price	2026-09-25	94.5
Published advisor forecast	2026-09-18	93.4
Published advisor forecast	2026-12-18	97.2
Published advisor forecast	2027-03-18	100
Published advisor forecast	2027-06-18	102
Published advisor forecast	2027-09-18	106
Published advisor forecast	2027-12-18	103
Published advisor forecast	2028-03-18	107
Published advisor forecast	2028-06-18	110
Published advisor forecast	2028-09-18	113
Published advisor forecast	2028-12-18	116
Published advisor forecast	2029-03-18	114
Published advisor forecast	2029-06-18	117
Published advisor forecast	2029-09-18	120
Published advisor forecast	2029-12-18	123
Published advisor forecast	2030-03-18	125
Published advisor forecast	2030-06-18	128
Published advisor forecast	2030-09-18	125
Published advisor forecast	2030-12-18	129
Published advisor forecast	2031-03-18	132
Published advisor forecast	2031-06-18	134
Published advisor forecast	2031-09-18	137

2. Scenarios & Signals

Bull case

The bull case activates when North America stops being an excuse and starts being a contributor. Mid-single-digit Americas growth alongside continued fragrance strength lifts group organic above 5%, dropping incremental revenue onto a cost base stripped of 10,000 positions, so margin reaches 15% by fiscal 2029 rather than 2031. Stronger cash flow then funds a restored buyback, shrinking share count while climbs, and the market re-rates the shares as a compounder again rather than a repair story.

Bear case

The bear case begins the moment investors realise the savings were the whole story. With PRGP exhausted, a Hormuz-driven travel-retail shock and Chinese prestige deflation stall near zero, leaving margin marooned around 13% and free cash flow insufficient to both deleverage against roughly $9.3bn of debt and defend brand spend. Guidance is cut, 2.34x interest coverage draws scrutiny, and a 3% grower gets repriced toward 18-20x earnings, taking the shares back toward their 52-week low.

Current crowd narrative

The settled belief is that the worst is over: four consecutive growth quarters, a 320bp adjusted margin expansion and FY2027 guidance of $3.10-$3.35 have made the turnaround consensus rather than contrarian [3][10]. Thirty analysts split 10 buy, 15 hold, one sell, averaging $107.65 [17]. The anchoring bias is the $66 low, which makes 29x forward earnings feel cheap.

Alpha-gap assessment

The crowd slightly overestimates these shares. The cost recovery is real and largely delivered, but the market treats $1.2bn of gross savings as shareholder property when the filings show a large share recycled into consumer-facing investment and offset by the securities-litigation settlement [12]. Strip that, and the durable engine is 3%-5% captured by taking share in a flat Chinese category, priced at roughly 29x with 2.34x interest coverage. The gap is modest, not dramatic; no compelling mispricing exists at $93.40.

Convergence catalyst

The FY2028 outlook, due August 2027, is the moment the market learns whether margin can advance without a restructuring programme. The first observable sign of repricing will be the Americas organic line and gross margin commentary at the 2 November 2026 Q1 print [23].

Paywalled preview begins: Macro-regime alignment

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Sentiment and regime

Greed and fear sentiment: 0.1
Expected volatility regime: high_erratic
Convergence-cycle position: growing_awareness

Primary drivers

Primary drivers supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
COST PLAN Converts TO RUN RATE Profit	The Profit Recovery and Growth Plan closed approvals on 30 June 2026 with $1.2bn gross benefits and roughly 10,000 positions removed [2][8]. FY2026 adjusted operating margin already expanded 320bps to 11.2% [3], and management affirmed 12.7%-13.5% for FY2027 with adjusted EPS of $3.10-$3.35 [10][9]. Most of the run-rate lands in FY2027, so the earnings step-up is contracted rather than hoped for.	Not available	+26.0%
Fragrance Carries THE MIX	Fragrance grew 10% in FY2026, led by Le Labo, Jo Malone and TOM FORD, while makeup's organic trend improved 500bps to roughly flat [1][5]. Luxury fragrance carries structurally higher gross margin and lower promotional intensity than mass-tier makeup, so mix alone lifts the 75.5% FY2026 gross margin. This persists because fragrance penetration among younger prestige buyers is still rising.	Not available	+12.0%
ASIA Travel Retail Reopens THE Funnel	Travel retail was about 15% of FY2026 reported sales, and Hainan posted double-digit Q4 retail sales growth [5]. Mainland China delivered 9% organic growth with 12% reported sales of $3bn, led by La Mer and Le Labo share gains [1][5]. This channel carries above-average margins; its recovery restores operating leverage on a fixed distribution base that was sized for pre-2022 volumes.	Not available	+11.0%
CASH Conversion Quietly Repaired	Operating cash flow reached $1.8bn in FY2026 against $1.3bn prior, with capex of $457m, producing free cash flow of $1.32bn despite heavy restructuring payments [5]. The dividend costs roughly 38% of cash flow even while GAAP payout screens at 279% [11]. Sustained conversion funds deleveraging first, then restores buyback capacity, which is the only per-share compounding lever left once savings are banked.	Not available	+9.0%

Primary frictions

Primary frictions supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Twenty NINE Times Meets FIVE Percent	At $93.40 the shares discount roughly 29x the midpoint of FY2027 adjusted EPS and about 33x guided reported EPS of $2.52-$2.85 [11], while the US 10-year yields 4.998% and the Fed funds range sits at 3.75%-4.00%. Long-duration staple multiples compress mechanically as the risk-free rate rises. Unless real yields fall, multiple erosion offsets a meaningful share of earnings growth across the horizon.	Not available	-19.0%
Share GAIN IN A FLAT POND	China reported nominal retail sales growth of just 0.4% YoY in August and January-August fixed investment down 7.2%, with property development down 19.9%. Estee Lauder's mainland momentum is therefore share capture inside a stagnant prestige category, not category expansion [1][5]. Share-gain engines decelerate as competitors respond with price; with China near 20% of sales, the arithmetic caps group organic growth near the low end of 3%-5%.	Not available	-13.0%
Dupes AND THE Stalled Americas	The Americas grew just 1% in FY2026 to $4.4bn, and management named North America growth a fiscal 2027 priority, which is an admission the largest region is not yet contributing [1][9]. Algorithmic discovery, indie brands and dupe substitution compress prestige pricing power exactly where brand equity was built on department-store gatekeeping. Recovering this region requires reinvestment of savings, capping incremental margin.	Not available	-11.0%
Tariffs Freight AND A Closed Strait	IEEPA tariffs cost $102m gross in FY2026, partially refunded by $38m after the February Supreme Court ruling, with Section 301 replacement duties now active [2][9]. Brent at $103.87 and disrupted Hormuz and Red Sea routing raise air freight and depress travel-retail footfall. Management assumes no material Middle East impact in fiscal 2027 [9]; that assumption is the single most fragile input in the guidance bridge.	Not available	-9.0%

Tail opportunities

Tail opportunities supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
North America Inflects Buyback Returns	If Americas organic growth moves from 1% toward mid-single digits during fiscal 2028 while PRGP savings hold, adjusted operating margin could reach 15% ahead of schedule and free cash flow exceed $1.8bn. With gross debt near $9.3bn already amortising, the board could restore meaningful repurchase against FY2026's token $70m, shrinking the share count and compounding EPS. Probability stays below 50% because North American prestige is the most dupe-exposed market and reinvestment there absorbs savings first; timing most plausibly late 2028 into 2029.	33.0%	+28.0%
Beijing Reflates THE Prestige Shopper	A decisive Chinese consumption stimulus, plausibly following the property drag easing in 2027-2028, would convert Estee Lauder's share gains into category growth. Mainland China at $3bn of sales plus Hainan travel retail carry above-group margins, so a return to high-single-digit category growth would lift group organic beyond 5% and drive positive operating leverage on an already restructured cost base [1][5]. It stays under 50% because Beijing has prioritised advanced manufacturing over household transfers, and January-August fixed investment fell 7.2%.	28.0%	+24.0%

Tail risks

Tail risks supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Margin Bridge Stalls After THE Savings	Once the $1.2bn PRGP benefit is fully in the base during fiscal 2027, there is no further structural cost lever disclosed. If FY2028 guidance shows margin plateauing near 13% rather than grinding toward 16%, the market reprices a 3% organic grower at roughly 20x instead of 29x. With interest coverage at 2.34x on a leveraged balance sheet, a soft topline would also slow deleveraging. Probability under 50% because mix and travel retail still offer runway; decision point arrives with FY2028 guidance in August 2027.	35.0%	-31.0%
Hormuz Shuts THE Travel Retail Spigot	A sustained Strait of Hormuz closure or a broader Gulf aviation disruption would cut long-haul passenger volumes through the Middle East hubs that feed Asian travel retail, roughly 15% of sales [5], while pushing jet fuel and air freight higher. Management explicitly assumes no material fiscal 2027 impact [9], so any hit arrives as a guidance cut rather than a pre-flagged headwind, and the shares de-rate on both earnings and credibility. Below 50% because partial routing workarounds exist; most acute risk window is 2027.	30.0%	-26.0%

Step-by-step forecast path

Universal Investor forecast path for prediction task predrqst_batch_task__xrefsubjtskconf_d7763a47-cb19-5456-b249-a286e54de85c__sb7__20260920064920277661
Step	Forecast date	Step change	Projected value (USD)	Scenario rationale
1	December 18, 2026	+4.0%	97.17	The 2 November Q1 FY2027 print, with consensus EPS of $0.51, confirms early PRGP run-rate conversion and fragrance momentum. Partial recovery from the September rate-hike drawdown, tempered by a five-percent ten-year yield capping multiple expansion.
2	March 18, 2027	+3.0%	100.08	The seasonally largest holiday quarter reports in February, with Hainan travel retail and luxury fragrance carrying growth. Margin bridge holds near guidance, but Americas organic growth remains soft, limiting the market's willingness to pay more.
3	June 18, 2027	+2.0%	102.08	Third-quarter results show GAAP converging toward adjusted as restructuring charges finally fade. Persistent inflation and high oil prices weigh on discretionary prestige demand, so the earnings improvement is absorbed rather than rewarded with a higher multiple.
4	September 18, 2027	+4.0%	106.17	FY2027 closes near the 12.7%-13.5% adjusted margin target and August guidance for FY2028 signals continued progress without a new restructuring programme. Delivery of the contracted cost story earns a modest relief move higher.
5	December 18, 2027	-3.0%	102.98	Post-savings reality check: with PRGP fully in the base, investors question the next margin lever. Renewed Gulf shipping disruption raises freight assumptions and pressures travel-retail forecasts, prompting a valuation pullback from the summer highs.
6	March 18, 2028	+4.0%	107.10	Holiday-quarter results show fragrance and Asian travel retail outperforming while North American reinvestment begins showing sequential improvement. Easing policy-rate expectations as inflation moderates support a higher multiple for long-duration staple cash flows.
7	June 18, 2028	+3.0%	110.31	Free cash flow above $1.5bn reduces gross debt and lifts interest coverage above three times. Improved balance-sheet quality narrows the risk premium, even as organic growth stays anchored in the guided three-to-five-percent band.
8	September 18, 2028	+2.0%	112.52	FY2028 results confirm margin advancing toward the mid-teens without another headcount programme. Gains are modest because Chinese prestige category growth remains stagnant and Estee Lauder's momentum still depends on taking share rather than expanding demand.
9	December 18, 2028	+3.0%	115.90	A resumed share repurchase authorisation, funded by restored cash conversion, becomes the incremental per-share lever after years of token buybacks. Share-count reduction adds directly to EPS and signals management confidence in the earnings base.
10	March 18, 2029	-2.0%	113.58	Competitive intensity in North American prestige rises as indie brands and dupe substitution pressure pricing. Promotional spend increases to defend shelf position, shaving incremental margin and prompting a modest de-rating of growth assumptions.
11	June 18, 2029	+3.0%	116.99	Easier global financing conditions lower the discount rate applied to staple cash flows. Fragrance portfolio extensions and China travel-retail throughput sustain low-to-mid single-digit organic growth, converting to faster earnings growth on the leaner cost base.
12	September 18, 2029	+3.0%	120.50	Fiscal-year results show adjusted operating margin near fifteen percent, halfway back to the 17.9% FY2022 peak. Delivery against a multi-year margin path rebuilds credibility that the 2024-2026 collapse destroyed.
13	December 18, 2029	+2.0%	122.91	Holiday demand is solid but unspectacular. Progress becomes incremental as the recovery narrative matures into a steady-compounder story, with the price advancing broadly in line with earnings rather than through further multiple expansion.
14	March 18, 2030	+2.0%	125.36	Continued deleveraging and buyback execution compound per-share earnings. Chinese consumption remains the swing factor; without category reflation, group organic growth holds near four percent and valuation stays anchored in the mid-twenties.
15	June 18, 2030	+2.0%	127.87	Product innovation cycles in luxury fragrance and skincare sustain premium pricing. Gains track earnings growth as the market applies a stable multiple to a business now judged on execution rather than on rescue.
16	September 18, 2030	-2.0%	125.31	A cyclical soft patch in discretionary spending, plausibly tied to slower US employment growth, trims travel-retail volumes. Prestige beauty proves less defensive than the staples label implies, producing a modest quarterly setback.
17	December 18, 2030	+3.0%	129.07	Recovery from the soft patch alongside a strong holiday fragrance season. Operating leverage on the restructured base converts revenue reacceleration into disproportionate earnings growth, restoring the upward path.
18	March 18, 2031	+2.0%	131.65	Margin approaches the mid-to-high teens and free cash flow supports a rising dividend alongside repurchase. The investment case is now conventional compounding, with valuation expansion no longer the primary return source.
19	June 18, 2031	+2.0%	134.29	Fiscal 2031 tracks toward roughly $18bn of revenue with EPS near five dollars. The market capitalises this at a mid-twenties multiple, consistent with a mature prestige-beauty franchise growing in the low-to-mid single digits.
20	September 18, 2031	+2.0%	136.97	Horizon close: cumulative appreciation of roughly forty-five percent plus dividends, an outcome close to equity-market returns. The turnaround has been fully harvested; further upside requires category growth rather than self-help.

Advisor and configuration

Advisor: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release
Persona: Universal Investor
Archetype: The Polymath
Model: 2026-07-24 release
Provider: Anthropic
Mode: RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity
Task configuration: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release__equity__json__extnd_invest_thesis_4q_alphassym__ts_num_desc__h5y_s3m__var1__researcher__standard_creativity_high_thinking__batch
Forecast horizon: 5 year
Forecast steps: 20 steps of 3 month
Assembly type: Balanced Assembly
Assembly name: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release RESEARCHER Forecast Assembly
Input format: inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1
Output format: Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)

Read the complete Universal Investor advisor methodology

Configuration components

aiassmprmtcmpnt_b995bbe2-6a15-55be-a576-525904f696e8
aiassmprmtcmpnt_c55d1851-d218-5d30-b83b-54bbda31e2ee
aiassmprmtcmpnt_930157b1-05d7-5699-bf0a-738645ee42fd
aiassmprmtcmpnt_3c0c459a-0d4a-50ca-87df-c172ec5618aa
aiassmprmtcmpnt_8115cc2a-d418-54b1-a616-49dfa91195f4

Research sources

[1]Reigniting growth: Asia travel retail recovery buoys The Estée Lauder Companies’ full-year results : Moodie Davitt Reportmoodiedavittreport.com
[2]Estée Lauder Q4 2026 earnings beat, fiscal 2027 profit forecastfinance.yahoo.com
[3]Estée Lauder Reports Fiscal 2026 Growth Amid Margin Expansion and Restructuring — The Estée Lauder Companies Inc. | BriefGlancebriefglance.com
[4]The Estee Lauder Companies Inc Class A (EL)morningstar.com
[5]Estée Lauder (EL) Q4 2026 Earnings Call Transcript | The Motley Foolfool.com
[6]Gloomgloom.sh
[7]Beauty company delivers harsh update to thousands of workers - AOLaol.com
[8]Estée Lauder to cut up to 10,000 jobs, targets $1.2bn in savingsme.peoplemattersglobal.com
[9]Estee Lauder Q4 2026: Fourth Straight Beat and a Bullish FY2027 Outlook | 24/7 Wall St.247wallst.com
[10]The Estée Lauder Companies Reports Fiscal 2026 Resultssecure.businesswire.com
[11]Estée Lauder Companies (NYSE:EL) - Stock Analysis - Simply Wall Stsimplywall.st
[12]ESTEE LAUDER COMPANIES INC - Form 10-K - FY2026sec.gov
[13]The Estée Lauder Companies & Puig End Discussions Regarding a Potential Business Combination – The Estée Lauder Companies Inc.elcompanies.com
[14]estee lauder confirms merger talks with spains puighl.co.uk
[15]Estée Lauder surges in premarket after Puig merger deal talks endcnbc.com
[16]estee lauder confirms talks with spanish perfume maker puigbarchart.com
[17]EL Forecast & Price Target - TradingKeytradingkey.com
[18]Estee Lauder Stock Price Today | NYSE: EL Live - Investing.cominvesting.com
[19]EL Stock Quote Price and Forecast | CNNcnn.com
[20]Free Trialmarketbeat.com
[21]Estée Lauder and Puig: What Was the $40 Billion Dealbreaker ? | BeautyMatterbeautymatter.com
[22]The Estée Lauder Companies Inc. (EL) Stock Price, News, Quote & History - Yahoo Financefinance.yahoo.com
[23]EL: The Estée Lauder Companies Inc. Stock Price, Chart & Key Stats | LuxAlgoluxalgo.com

Back to advisor navigation

End of the paywalled preview

The excerpt from Macro-regime alignment to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Other AI Advisor reports — limited previews

Sherlock Holmes — RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity

Gemini 3.8 Flash

Limited structural preview, provided as simplified HTML. The complete report contains substantially more research: its investment thesis; bull and bear scenarios; macro-regime analysis; drivers, risks and opportunities; quarterly forecast tables and rationale; references and published configuration. Those findings and datasets are not included here. Sign in with the required subscription to open this advisor's full report.